Incyte Stock Plummets Post-Trial
This is a news story, published by Yahoo Finance, that relates primarily to hidradenitis suppurativa news.
hidradenitis suppurativa news
For more hidradenitis suppurativa news, you can click here:
more hidradenitis suppurativa newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
investigational skin disorder drug. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Clinical trials news, acne inversa news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
severe hidradenitis suppurativaThe Motley Fool
•Health
Health
Incyte stock is tanking after a less-than-encouraging clinical trial results

64% Informative
Incyte published the top-line results from two phase 3 trials of its povorcitinib, a treatment aimed at combating moderate to severe hidradenitis suppurativa (HS), also known as acne inversa.
The biotech's share price was down by nearly 11% week to date as of Friday .
VR Score
53
Informative language
50
Neutral language
8
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
6
Source diversity
2
Affiliate links
no affiliate links